Loading...
Home / Semaglutide-Tirzepatide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It has trade names as Wegovy and Ozempic.
It mimics the GLP-1 hormone that is released in the gastrointestinal tract in response to eating. GLP-1 prompts the body to produce more insulin, which reduces blood glucose (sugar).
Invest in your health for just $299/month. No more excuses.
Tirzepatide is a dual agonist that mimics the action of GLP-1 and GIP receptors to regulate appetite, insulin secretion, and glucose metabolism. It is also known as Zepbound and the FDA-approved trade name Mounjaro.
The dual-action mechanism of Tirzepatide makes it a powerful tool for weight management.
Invest in your health for just $499/month. No more excuses.
Appetite Suppression: Reduces hunger by acting on brain receptors.
Increased Satiety: Slows down gastric emptying for prolonged fullness.
Improved Blood Sugar Control: Stabilizes blood sugar levels.
Fat Reduction: Stimulates brown adipose tissue for fat burning.
Appetite Suppression: Reduces hunger by acting on brain receptors.
Increased Satiety: Slows down gastric emptying for prolonged fullness.
Improved Blood Sugar Control: Stabilizes blood sugar levels.
Fat Reduction: Triggers fat metabolism via MC4R binding.
Please reach us if you cannot find an answer to your question.